• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疏水标签连接降解,新兴的靶向蛋白降解策略。

Hydrophobic Tag Tethering Degradation, The Emerging Targeted Protein Degradation Strategy.

机构信息

Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Department of Chemistry, Zhejiang Normal University, 688 Yingbin Road, Jinhua 321004, P.R. China.

Drug Development and Innovation Center, College of Chemistry and Life Sciences, Zhejiang Normal University, 688 Yingbin Road, Jinhua 321004, P.R. China.

出版信息

Curr Med Chem. 2023;30(27):3137-3155. doi: 10.2174/0929867329666220930120328.

DOI:10.2174/0929867329666220930120328
PMID:36200255
Abstract

Targeted protein degradation (TPD) strategies have become a new trend in drug discovery due to the capability of triggering the degradation of protein of interest (POI) selectively and effectively in recent decades. Particularly, the hydrophobic tag tethering degrader (HyTTD) has drawn a lot of attention and may offer a promising strategy for new drug research and development in the future. Herein, we will give an overview of the development of HyTTD, the structure-activity relationship (SAR) between HyTTD and linkers, HyTs, and ligand motifs, as well as the various HyTTDs targeting different targets, thus offering a rational strategy for the design of HyTTDs in further TPD drug discovery.

摘要

靶向蛋白降解(TPD)策略在近几十年来因其能够选择性和有效地引发靶蛋白(POI)降解而成为药物发现的新趋势。特别是疏水标签连接降解剂(HyTTD)引起了广泛关注,可能为未来新药研究和开发提供有前景的策略。在此,我们将概述 HyTTD 的发展、HyTTD 与连接子、HyTs 和配体基序之间的结构-活性关系(SAR),以及针对不同靶标的各种 HyTTD,从而为进一步的 TPD 药物发现中 HyTTD 的设计提供合理策略。

相似文献

1
Hydrophobic Tag Tethering Degradation, The Emerging Targeted Protein Degradation Strategy.疏水标签连接降解,新兴的靶向蛋白降解策略。
Curr Med Chem. 2023;30(27):3137-3155. doi: 10.2174/0929867329666220930120328.
2
A novel hydrophobic tag leads to the efficient degradation of programmed death-ligand 1.一种新型疏水标签可导致程序性死亡配体1的有效降解。
RSC Med Chem. 2024 Jul 4;15(9):3038-3047. doi: 10.1039/d4md00320a. eCollection 2024 Sep 19.
3
Small-Molecule Hydrophobic Tagging: A Promising Strategy of Druglike Technology for Targeted Protein Degradation.小分子疏水标记:一种有前景的靶向蛋白降解类药技术策略。
J Med Chem. 2023 Aug 24;66(16):10917-10933. doi: 10.1021/acs.jmedchem.3c00736. Epub 2023 Aug 3.
4
Hydrophobic tag-based protein degradation: Development, opportunity and challenge.基于疏水标签的蛋白质降解:发展、机遇与挑战。
Eur J Med Chem. 2023 Nov 15;260:115741. doi: 10.1016/j.ejmech.2023.115741. Epub 2023 Aug 19.
5
Nucleic-Acid-Based Targeted Degradation in Drug Discovery.基于核酸的药物发现中的靶向降解。
J Med Chem. 2022 Aug 11;65(15):10217-10232. doi: 10.1021/acs.jmedchem.2c00875. Epub 2022 Aug 2.
6
Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer.靶向蛋白质降解:癌症治疗的新兴策略
Anticancer Agents Med Chem. 2021;21(2):214-230. doi: 10.2174/1871520620666200410082652.
7
Emerging degrader technologies engaging lysosomal pathways.新兴的降解剂技术涉及溶酶体途径。
Chem Soc Rev. 2022 Oct 31;51(21):8832-8876. doi: 10.1039/d2cs00624c.
8
Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation.发现降冰片烯作为一种新型疏水性标签应用于蛋白质降解。
Angew Chem Int Ed Engl. 2023 Mar 20;62(13):e202217246. doi: 10.1002/anie.202217246. Epub 2023 Feb 8.
9
Targeted protein degradation and drug discovery.靶向蛋白降解与药物发现。
J Biochem. 2022 Jul 25;172(2):61-69. doi: 10.1093/jb/mvac041.
10
Molecular glue degraders: exciting opportunities for novel drug discovery.分子胶降解剂:新药研发的激动人心机遇。
Expert Opin Drug Discov. 2024 Apr;19(4):433-449. doi: 10.1080/17460441.2024.2306845. Epub 2024 Jan 24.

引用本文的文献

1
A novel hydrophobic tag leads to the efficient degradation of programmed death-ligand 1.一种新型疏水标签可导致程序性死亡配体1的有效降解。
RSC Med Chem. 2024 Jul 4;15(9):3038-3047. doi: 10.1039/d4md00320a. eCollection 2024 Sep 19.